InvestorsHub Logo
Followers 132
Posts 6427
Boards Moderated 0
Alias Born 05/13/2014

Re: Uncle Gee Gee post# 26421

Wednesday, 10/14/2020 8:50:23 AM

Wednesday, October 14, 2020 8:50:23 AM

Post# of 44690
Agreed. And looking at the NeuroRx team and where they come from ... JJ, Pfizer, Eli Lilly ....

Just for those thinking that there is some sort of “direct competition” between big pharma & Neuro or RLF .... we are an “appendage” of sorts...

“NeuroRx draws upon more than 100 years of collective drug development experience and is led by former senior executives of Johnson & Johnson, Eli Lilly, Pfizer, and AstraZeneca, PPD. In addition to its work on RLF-100, NeuroRx has been awarded Breakthrough Therapy Designation and a Special Protocol Agreement to develop NRX-101 for the treatment of suicidal bipolar depression and is currently in Phase 3 trials. Its Board of Directors and Advisors includes Hon. Sherry Glied, former Assistant Secretary, U.S. Dept. of Health and Human Services; Mr. Chaim Hurvitz, former President of the Teva International Group; Lt. Gen. HR McMaster, the 23rd National Security Advisor; Wayne Pines, former Associate Commissioner of the U.S. Food and Drug Administration; Judge Abraham Sofaer; and Daniel Troy, former Chief Counsel, U.S. Food and Drug Administration.”

$RLFTF